References
Menard DB, Gisselbrecht C, Marty M, Rayes F, Dhumeaux D: Antineoplastic agents and the liver. Gastroenterology 78:142–164, 1980
Robinson JK, Baughamn RD, Auerbach R, Cimis RJ: Methotrexate hepatotoxicity in psoriasis-consideration of liver biopsies at regular intervals. Arch Dermatol 116:413–415, 1980
Dahl MGC, Gregory MM, Scheuer PJ: Methotrexate hepatotoxicity in psoriasis-comparison of different dose regimens. Br Med J 1:645–656, 1972
Nyfors A: Benefits and adverse drug experiences during long-term methotrexate treatment of 248 psoriatics. Dan Med Bull 25:208–211, 1978
Roenigk HH Jr, Auerbach R, Bergfeld WF, Frost P, Maibach HI, Tindall J, Weinstein GD: A cooperative prospective study of the effects of chemotherapy of psoriasis on liver biopsies. In Psoriasis. Proceedings of the Second International Symposium. EM Farber, AJ Cox (eds). New York, Yorke Medical Books, 1977, pp 243–248
Warin AP, Landells JW, Levene GM, Baker H: A prospective study of the effects of weekly oral methotrexate on liver biopsy. Findings in severe psoriasis. Br J Dermato 93:321–327, 1975
Weinstein G, Roenigk H, Maibach H, Cosmides J, Halprin K, Millard M: Psoriasis-liver methotrexate interactions. Arch Dermatol 108:36–42, 1973
Zachariae H, Kragbulle K, Sogaard H: Methotrexate-induced liver cirrhosis. Br J Dermatol 102:407–412, 1980
Pestana A, Halprin KM, Taylor JR, Schiff ER, Esquenazi V, Comerford M, Gomez C: Predictive value of HLA antigen for methotrexate-induced liver damage in patients with psoriasis. J Am Acad Dermatol 12:26–29, 1985
Roenigk HH, Auerbach R, Maibach HI, Weinstein GD: Methotrexate guidelines-revised. J Am Acad Dermatol 6:145–155, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taylor, J.R., Halprin, K.M. & Schiff, E.R. Oral methotrexate. Digest Dis Sci 31, 443–444 (1986). https://doi.org/10.1007/BF01311685
Issue Date:
DOI: https://doi.org/10.1007/BF01311685